Primemd Inc.
Primemd Inc. Fundamental Analysis
Primemd Inc. (PRMD) shows strong financial fundamentals with a PE ratio of 0.00, profit margin of 29.90%, and ROE of 73.34%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze PRMD's fundamental strength across five key dimensions:
Efficiency Score
ExcellentPRMD demonstrates superior asset utilization.
Valuation Score
ExcellentPRMD trades at attractive valuation levels.
Growth Score
WeakPRMD faces weak or negative growth trends.
Financial Health Score
ExcellentPRMD maintains a strong and stable balance sheet.
Profitability Score
ExcellentPRMD achieves industry-leading margins.
Key Financial Metrics
Is PRMD Expensive or Cheap?
P/E Ratio
PRMD trades at 0.00 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, PRMD's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Primemd Inc. at 0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -1.32 times EBITDA. This is generally considered low.
How Well Does PRMD Make Money?
Net Profit Margin
For every $100 in sales, Primemd Inc. keeps $29.90 as profit after all expenses.
Operating Margin
Core operations generate 39.60 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $73.34 in profit for every $100 of shareholder equity.
ROA
Primemd Inc. generates $20.49 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Primemd Inc. generates strong operating cash flow of $3.02M, reflecting robust business health.
Free Cash Flow
Primemd Inc. generates strong free cash flow of $2.24M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.12 in free cash annually.
FCF Yield
PRMD converts 173.09% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.004
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.002
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.001
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.97
vs 25 benchmark
Current Ratio
Current assets to current liabilities
16.52
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.73
vs 25 benchmark
ROA
Return on assets percentage
0.20
vs 25 benchmark
ROCE
Return on capital employed
0.28
vs 25 benchmark
How PRMD Stacks Against Its Sector Peers
| Metric | PRMD Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.00 | 27.91 | Better (Cheaper) |
| ROE | 73.34% | 687.00% | Weak |
| Net Margin | 29.90% | -45285.00% (disorted) | Strong |
| Debt/Equity | 0.97 | 0.33 | Weak (High Leverage) |
| Current Ratio | 16.52 | 2795.76 | Strong Liquidity |
| ROA | 20.49% | -13557.00% (disorted) | Strong |
PRMD outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Primemd Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation